That stands for glucagon-like peptide-1, which is a hormone that we produce in our guts
The glucagon receptor component increases energy expenditure and fat oxidation
While Dihexa-specific desensitization kinetics haven't been thoroughly characterized in long-term studies, applying known c-Met receptor regulation patterns suggests daily dosing beyond 46 weeks without rest periods would likely produce diminishing returns
Most common side effects were gastrointestinal, with 24.5% of participants in the phase 2 obesity trial discontinuing efinopegdutide 10 mg due to AE however when the same dose was used with gradual escalation at the MASLD trial (starting dose 2.4 mg for 4 weeks, then 5 mg for 4 weeks and then 10 mg), only 5.6% of participants discontinued the medication due to AE
Main ingredients: Copper Tripeptide-1, Acetyl Tetrapeptide-3, Trifolium Pratense Flower Extract, Arginine, Panthenol, Niacinamide, Sodium Hyaluronate and Allantoin